DoD Lupus, Idea Award | W81XWH 22 LRP IA

Opportunity Information: Apply for W81XWH 22 LRP IA

The DoD Lupus Research Program (LRP) Idea Award (Funding Opportunity Number W81XWH 22 LRP IA) is a discretionary Department of Defense funding opportunity administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA) to support bold, early-stage lupus research. The central goal is to back innovative, high-risk/high-reward ideas that could realistically open up entirely new directions in lupus investigation and, if successful, lead to a major advancement or critical discovery relevant to lupus. This mechanism is designed for projects that challenge current thinking or apply fresh perspectives to difficult problems in lupus, rather than extending an existing, well-established research line.

A key expectation is that applicants clearly explain what is genuinely new about their concept and why it matters. The proposal must lay out how the idea will either enhance existing knowledge of lupus or generate a new hypothesis (or hypotheses) and an original research path. Reviewers are looking for true innovation, such as introducing a new paradigm, reframing an established question in an unconventional way, or applying a creative approach that is not simply the next logical step from prior published findings. Because of that emphasis, the Idea Award is explicitly not meant to fund incremental work or routine continuation of ongoing projects.

Impact is treated as a central review consideration alongside innovation. Applications need to spell out what meaningful difference the work could make for lupus, particularly if the project succeeds. The program stresses that the most competitive submissions will describe potential benefits that are significant to people living with lupus and will argue convincingly that the outcomes could shift understanding or practice in an important area of the disease. Work that mainly adds a small amount of detail to existing literature is not considered sufficiently impactful for this mechanism.

On the scientific plan, the award requires a strong research strategy grounded in a clear rationale and a thoughtful experimental design that demonstrates deep understanding of lupus biology and the state of the field. Methods can be novel, but they can also be established techniques if they are used in a creative way and are backed by a solid logic derived from the literature. Importantly, preliminary data are not required, reflecting the program's intent to enable exploration of promising ideas that are still at an early stage. At the same time, the research must align with at least one of the FY22 LRP Focus Areas, meaning the project must fit within the priority topics defined for that funding year. Clinical trials are not permitted under this announcement.

Funding is provided through an assistance agreement, which can be issued as either a grant or a cooperative agreement. The choice depends on how much involvement the DoD anticipates having during the project. If substantial federal involvement is not expected, the award is made as a grant; if collaboration or active participation by the DoD is expected, a cooperative agreement is used and will specify the nature of that involvement. The maximum anticipated total cost for the entire period of performance is capped at $300,000 per Idea Award.

From a program budget and competitiveness standpoint, the CDMRP expected to allocate about $1.2 million total to fund approximately four Idea Award projects. Actual funding depends on federal fund availability, the number of applications submitted, and how proposals score in scientific and programmatic review relative to program priorities. The original application closing date listed for this opportunity was September 1, 2022, with awards expected to be made no later than September 30, 2023, using FY22 funds that were time-limited and set to expire for use on September 30, 2023. Eligibility is listed as unrestricted, meaning it is broadly open to a wide range of applicant organizations, subject to any additional eligibility clarifications in the full announcement.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Lupus, Idea Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 17, 2022.
• Applicants must submit their applications by Sep 01, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 4 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 22 LRP IA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: